Список литературы

261. Williams T., Machann W., Kühler L. et al. Novel desmoplakin mutation: juvenile biventricular cardiomyopathy with left ventricular non-compaction and acantholytic palmoplantar keratoderma // Clin. Res. Cardiol. 2011. Vol. 100, N 12. P. 1087-1093.

262. Wlodarska E.K., Wozniak O., Konka M. et al. Isolated ventricular noncompaction mimicking arrhythmogenic right ventricular cardiomyopathy - a study of nine patients // Int. J. Cardiol. 2010. Vol. 145, N 1. P. 107-111.

263. Wrigley B.J., Rosin M., Banerjee P. Replacement of a congenital bicuspid aortic valve in a patient with left ventricular noncompaction // Tex. Heart Inst. J. 2009. Vol. 36, N 3. P. 241-243.

264. Yavuzgil O., Gürgün C., Soydas Cinar C., Yüksel A. Anterior myocardial infarction in an adult patient with left ventricular hypertrabeculation/noncompaction // Int. J. Cardiol. 2006. Vol. 106, N 3. P. 394-395.

265. Yildiz A., Tufekcioglu O., Aras D. et al. Myocardial noncompaction presenting with Brucella endocarditis // Int. J. Cardiol. 2009. Vol. 131, N 3. P. e87-e89.

266. Yin K., Ding L., Li Y., Hua W. Long-term follow-up of arrhythmogenic right ventricular cardiomyopathy patients with an implantable cardioverter-defibrillator for prevention of sudden cardiac death // Clin. Cardiol. 2017. Vol. 40, N 4. P. 216-221.

267. Yu C., Zhu T.G., Liu W.L., Huang W.F. Left-dominant arrhythmogenic cardiomyopathy: a case misdiagnosed as pseudoaneurysm // Chin. Med. J. (Engl.). 2016. Vol. 129, N 14. P. 1763-1764.

268. Zhang X., Yuan L., Qiu L. et al. Incremental value of contrast echocardiography in the diagnosis of left ventricular noncompaction // Front. Med. 2016. Vol. 10, N 4. P. 499-506.

269. Zorzi A., Elmaghawry M., Rigato I. et al. Exercise-induced normalization of right precordial negative t waves in arrhythmogenic right ventricular cardiomyopathy // Am. J. Cardiol. 2013. Vol. 112, N 3. P. 411-415.

1. Вест С.Дж. Секреты ревматологии. М. : Бином, 2001. С. 188-198.

2. Гадаев И.Ю., Ершов В.И., Бокарникова О.В. и др. Поражение сердца при лимфомах. Обзор литературы и описание случая клинического течения В-крупноклеточной лимфомы // Рационал. фармакотер. в кардиологии. 2015. Т. 11, № 6. С. 610-617.

3. Давыдов М.И., Дземешкевич С.Л., Герасимов С.С. и др. Случай успешного хирургического лечения больного первичной опухолью сердца // Вестн. моск. онкол. о-ва. 2008. № 11. С. 2-3.

4. Дземешкевич С.Л., Фролова Ю.В., Ким С.Ю. и др. Анатомические и морфологические признаки диффузно-генерализованной формы гипертрофической кардиомиопатии // Рос. кардиол. журн. 2015. № 5 (121). С. 58-63.

5. Жданова Е.А, Рамеев В.В., Моисеев С.В. и др. Амилоидоз сердца // Клин. фармакол. и тер. 2011. Т. 20, № 5. С. 44-50.

6. Окороков А.Н. Диагностика болезней внутренних органов : руководство. Т. 8. Диагностика болезней сердца и сосудов: болезни миокарда, сердечная недостаточность. М. : Мед. лит., 2007. 418 с.

7. Петровский Б.В., Константинов Б.А., Нечаенко М.А. Первичные опухоли сердца. М. : Медицина, 1997. 148 с.

8. Сухачева Т.В., Васковский В.А., Серов Р.А., Ревишвили А.Ш. Изолированный амилоидоз предсердий у пациентов с фибрилляцией предсердий // Бюл. НЦССХ им. А.Н. Бакулева. 2015. Т. 16, № S3. С. 184.

9. Ackerman M.J., Priori S.G., Willems S. et al. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA) // Europace. 2011. Vol. 13, N 8. P. 1077-1109.

10. Adler A., Fourey D., Weissler-Snir A. et al. Safety of outpatient initiation of disopyramide for obstructive hypertrophic cardiomyopathy patients // J. Am. Heart Assoc. 2017. Vol. 6, N 6. pii: e005152.

11. Akhter S., Bueltmann K. Jr, Huang X., Jin J.P. Restrictive cardiomyopathy mutations demonstrate functions of the C-terminal end-segment of troponin I // Arch. Biochem. Biophys. 2014. Vol. 552-553. P. 3-10.

12. Allanore Y., Meune C., Vonk M.C. et al. Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis // Ann. Rheum. Dis. 2010. Vol. 69. P. 218-221.

13. Anderson L.J., Westwood M.A., Holden S. et al. Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2* cardiovascular magnetic resonance // Br. J. Haematol. 2004. Vol. 127, N 3. P. 348-355.

14. Arbustini E., Pasotti M., Pilotto A. et al. Desmin accumulation restrictive cardiomyopathy and atrioventricular block associated with desmin gene defects // Eur. J. Heart Fail. 2006. Vol. 8, N 5. P. 477-483.

15. Authors/Task Force members; Elliott P.M., Anastasakis A., Borger M.A. et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC) // Eur. Heart J. 2014. Vol. 35, N 39. P. 2733-2779.

16. Badar T., Cornelison A.M., Shah N.D. et al. Outcome of patients with systemic light chain amyloidosis with concurrent renal and cardiac involvement // Eur. J. Haematol. 2016. Vol. 97, N 4. P. 342-347.

17. Beedupalli J., Modi K. Early-stage Loeffler’s endocarditis with isolated right ventricular involvement: management, long-term follow-up, and review of literature // Echocardiography. 2016. Vol. 33, N 9. P. 1422-1427.

18. Bennani Smires Y., Victor G., Ribes D. et al. Pilot study for left ventricular imaging phenotype of patients over 65 years old with heart failure and preserved ejection fraction: the high prevalence of amyloid cardiomyopathy // Int. J. Cardiovasc. Imaging. 2016. Vol. 32, N 9. P. 1403-1413.

19. Bergler-Klein J., Knoebl P., Kos T. et al. Myocardial involvement in a patient with Burkitt’s lymphoma mimicking hypertrophic cardiomyopathy // J. Am. Soc. Echocardiogr. 2003. Vol. 16, N 12. P. 1326-1330.

20. Biagini E., Olivotto I., Iascone M. et al. Significance of sarcomere gene mutations analysis in the end-stage phase of hypertrophic cardiomyopathy // Am. J. Cardiol. 2014. Vol. 114, N 5. P. 769-776. pii: S0002-9149(14)01309-5.

21. Biagini E., Ragni L., Ferlito M. et al. Different types of cardiomyopathy associated with isolated ventricular noncompaction // Am. J. Cardiol. 2006. Vol. 98, N 6. P. 821-824.

22. Biegstraaten M., Arngrímsson R., Barbey F. et al. Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus document // Orphanet J. Rare Dis. 2015. Vol. 10. P. 36.

23. Boentert M., Florian A., Dräger B. et al. Pattern and prognostic value of cardiac involvement in patients with late-onset pompe disease: a comprehensive cardiovascular magnetic resonance approach // J. Cardiovasc. Magn. Reson. 2016. Vol. 18, N 1. P. 91.

24. Breuckmann F., Möhlenkamp S., Nassenstein K. et al. Myocardial late gadolinium enhancement: prevalence, pattern, and prognostic relevance in marathon runners // Radiology. 2009. Vol. 251, N 1. P. 50-57.

25. Burke A., Tavora F. Practical Cardiovascular Pathology. Philadelphia : Wolters Kluwer Health; Lippincott Williams and Wilkins, 2011. 564 р.

26. Butterfield J.H., Kane G.C., Weiler C.R. et al. Hypereosinophilic syndrome: endomyocardial biopsy versus echocardiography to diagnose cardiac involvement // Postgrad. Med. 2017. Vol. 129, N 5. P. 517-523.

27. Captur G., Lopes L.R., Patel V. et al. Abnormal cardiac formation in hypertrophic cardiomyopathy: fractal analysis of trabeculae and preclinical gene expression // Circ. Cardiovasc. Genet. 2014. Vol. 7, N 3.P. 241-248.

28. Caselli S., Maron M.S., Urbano-Moral J.A. et al. Differentiating left ventricular hypertrophy in athletes from that in patients with hypertrophic cardiomyopathy // Am. J. Cardiol. 2014. Vol. 114, N 9. P. 1383-1389.

29. Castano A., Haq M., Narotsky D.L. et al. Multicenter study of planar technetium 99m pyrophosphate cardiac imaging: predicting survival for patients with ATTR cardiac amyloidosis // JAMA Cardiol. 2016. Vol. 1, N 8. P. 880-889.